Literature DB >> 26506952

Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.

Francisco C Carnevale1,2, Alexandre Iscaife3, Eduardo M Yoshinaga4, Airton Mota Moreira5, Alberto A Antunes6, Miguel Srougi7.   

Abstract

PURPOSE: To compare clinical and urodynamic results of transurethral resection of the prostate (TURP) to original and PErFecTED prostate artery embolization (PAE) methods for benign prostatic hyperplasia.
METHODS: We prospectively randomized 30 patients to receive TURP or original PAE (oPAE) and compared them to a cohort of patients treated by PErFecTED PAE, with a minimum of 1-year follow-up. Patients were assessed for urodynamic parameters, prostate volume, international prostate symptom score (IPSS), and quality of life (QoL).
RESULTS: All groups were comparable for all pre-treatment parameters except bladder contractility and peak urine flow rate (Q max), both of which were significantly better in the TURP group, and IIEF score, which was significantly higher among PErFecTED PAE patients than TURP patients. All groups experienced significant improvement in IPSS, QoL, prostate volume, and Q max. TURP and PErFecTED PAE both resulted in significantly lower IPSS than oPAE but were not significantly different from one another. TURP resulted in significantly higher Q max and significantly smaller prostate volume than either original or PErFecTED PAE but required spinal anesthesia and hospitalization. Two patients in the oPAE group with hypocontractile bladders experienced recurrence of symptoms and were treated with TURP. In the TURP group, urinary incontinence occurred in 4/15 patients (26.7 %), rupture of the prostatic capsule in 1/15 (6.7 %), retrograde ejaculation in all patients (100 %), and one patient was readmitted for temporary bladder irrigation due to hematuria.
CONCLUSIONS: TURP and PAE are both safe and effective treatments. TURP and PErFecTED PAE yield similar symptom improvement, but TURP is associated with both better urodynamic results and more adverse events.

Entities:  

Keywords:  Embolization/embolisation/embolotherapy; Prostate; Therapy; Urinary tract

Mesh:

Year:  2015        PMID: 26506952     DOI: 10.1007/s00270-015-1202-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  48 in total

Review 1.  Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.

Authors:  Jeremy Y C Teoh; Peter K F Chiu; Chi-Hang Yee; Hon-Ming Wong; Chi-Kwok Chan; Eddie S Y Chan; Simon S M Hou; Chi-Fai Ng
Journal:  Int Urol Nephrol       Date:  2016-11-28       Impact factor: 2.370

Review 2.  State of the art of prostatic arterial embolization for benign prostatic hyperplasia.

Authors:  Mario Petrillo; Filippo Pesapane; Enrico Maria Fumarola; Ilaria Emili; Marzia Acquasanta; Francesca Patella; Salvatore Alessio Angileri; Umberto G Rossi; Igor Piacentini; Antonio Maria Granata; Anna Maria Ierardi; Gianpaolo Carrafiello
Journal:  Gland Surg       Date:  2018-04

3.  Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

Authors:  J Curtis Nickel; Lorne Aaron; Jack Barkin; Dean Elterman; Mahmoud Nachabé; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2018-10       Impact factor: 1.862

4.  Reasons to consider prostatic artery embolization.

Authors:  Dominik Abt; Hans-Peter Schmid; Mark J Speakman
Journal:  World J Urol       Date:  2021-02-10       Impact factor: 4.226

Review 5.  Review of Current Literature for Prostatic Artery Embolization.

Authors:  Hyeon Yu; Ari J Isaacson; Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

Review 6.  Prostate artery embolization: a new, minimally invasive treatment for lower urinary tract symptoms secondary to prostate enlargement.

Authors:  Drew Maclean; Ben Maher; Sachin Modi; Mark Harris; Jonathan Dyer; Bhaskar Somani; Nigel Hacking; Timothy Bryant
Journal:  Ther Adv Urol       Date:  2017-07-10

7.  Clinical optimal dose of solifenacin succinate for nursing patients after transurethral resection of the prostate during the perioperative period.

Authors:  Baodi Zhang; Jia Wei; Xuan Wu; Lei Wang; Hongdan Huo; Junrong Wang
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

Review 8.  Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Peng Xiang; Di Guan; Zhen Du; Yongxiu Hao; Wei Yan; Yonghui Wang; Yutong Liu; Dan Liu; Hao Ping
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

Review 9.  Indications, techniques, and role of new minimally invasive benign prostate hyperplasia surgical options.

Authors:  Serdar Yalçın; Lütfi Tunç
Journal:  Turk J Urol       Date:  2020-07-02

10.  An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia.

Authors:  Xin Jian Xu; Jingjing Li; Xiang Zhong Huang; Qiang Liu
Journal:  World J Urol       Date:  2019-12-07       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.